Compositions, kit and one-step method for monitoring compounds having antifactor Xa and/or anti factor iia activities

Details for Australian Patent Application No. 2005243161 (hide)

Owner Heptest Laboratories, Inc.

Inventors Yin, Thye

Agent Pipers

Pub. Number AU-A-2005243161

PCT Pub. Number WO2005/111231

Priority 60/570,312 11.05.04 US

Filing date 10 May 2005

Wipo publication date 24 November 2005

International Classifications

C12Q 1/56 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/111231 Priority application(s): WO2005/111231

29 November 2007 Section 223 Application Allowed

  Heptest Laboratories, Inc. The time in which to request Examination has been extended to 27 Oct 2007. Address for service in Australia - Pipers Suite 1, Coronation Place 10 Benson Street Toowong QLD 4066

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243168-Compounds for enzyme inhibition

2005243158-Method of forming mesenchymal stem cells from embryonic stem cells